Petlife Pharmaceuticals Inc PTLF:Over The Counter Market

Last Price$0.0020Over The Counter Market Previous Close - Last Trade as of 3:07PM ET 7/11/22
Over The Counter Market 15-minute delayed Bid/Ask Quotes
Today's Change0.00(0.00%)
Bid (Size)$0.0001 (10,000)
Ask (Size)$0.25 (2,500)
Day Low / High$0.0020 - 0.0020
Volume50.00
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/11/2022

 

Petlife Pharmaceuticals Inc ( OTC )

Price: $0.002
Change: 0.00 (0.00%)
Volume: 50.00
3:07PM ET 7/11/2022
 
 

Bio-Bridge Science Inc ( OTC )

Price: $0.005
Change: 0.00 (0.00%)
Volume: 42.8 K
10:31AM ET 9/27/2021
 
 

Immunotech Laboratories Inc ( OTC )

Price: $0.0008
Change: 0.00 (0.00%)
Volume: 300.00
9:30AM ET 7/22/2022
 
 

Synergy CHC Corp ( OTC )

Price: $0.0055
Change: 0.00 (0.00%)
Volume: 2.0 K
12:02PM ET 6/06/2022
 
 

Alseres Pharmaceuticals Inc ( OTC )

Price: $0.01
Change: 0.00 (0.00%)
Volume: 20.00
5:09PM ET 2/23/2022
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionPetlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. Its products include preventative, tabs, and pet foods under the brand name Vitalzul. The company was founded on April 5, 2002 and is headquartered in Los Angeles, CA. View company web site for more details
Address8033 Sunset Boulevard
Los Angeles, California 90046
Phone+1.424.216.6807
Number of Employees1
Chairman, President, CEO, CFO & SecretarySebastian Serrell-Watts
Chief Medical OfficerVivek Ramana

Company Highlights

Price Open$0.002
Previous Close$0.002
52 Week Range$0.0001 - 0.0047
Market Capitalization$444.2 K
Shares Outstanding222.1 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity230.00%